ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 104 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $264,000 | +125.6% | 22,236 | 0.0% | 0.01% | +133.3% |
| Q1 2019 | $117,000 | +67.1% | 22,236 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $70,000 | -48.1% | 22,236 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $135,000 | +14.4% | 22,236 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $118,000 | -8.5% | 22,236 | 0.0% | 0.00% | -20.0% |
| Q1 2018 | $129,000 | +65.4% | 22,236 | 0.0% | 0.01% | +66.7% |
| Q4 2017 | $78,000 | -3.7% | 22,236 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $81,000 | +44.6% | 22,236 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $56,000 | -6.7% | 22,236 | 0.0% | 0.00% | -25.0% |
| Q1 2017 | $60,000 | -6.2% | 22,236 | 0.0% | 0.00% | -33.3% |
| Q4 2016 | $64,000 | -29.7% | 22,236 | 0.0% | 0.01% | -14.3% |
| Q3 2016 | $91,000 | +30.0% | 22,236 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $70,000 | – | 22,236 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 178,654 | $652,000 | 0.48% |
| EcoR1 Capital, LLC | 762,947 | $2,785,000 | 0.37% |
| VHCP Management II, LLC | 280,000 | $1,022,000 | 0.28% |
| MANGROVE PARTNERS IM, LLC | 413,838 | $1,511,000 | 0.26% |
| Sessa Capital IM, L.P. | 638,712 | $2,331,000 | 0.26% |
| 683 Capital Management, LLC | 550,000 | $2,008,000 | 0.21% |
| Rhenman & Partners Asset Management AB | 154,006 | $562,000 | 0.07% |
| ELEMENT CAPITAL MANAGEMENT LLC | 35,346 | $129,000 | 0.05% |
| Tekla Capital Management LLC | 300,078 | $1,095,000 | 0.04% |
| Marquette Asset Management, LLC | 25,998 | $95,000 | 0.04% |